Aptamer Sciences (Korea) Performance
| 291650 Stock | KRW 1,859 16.00 0.85% |
On a scale of 0 to 100, Aptamer Sciences holds a performance score of 5. The firm shows a Beta (market volatility) of -0.93, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Aptamer Sciences are expected to decrease slowly. On the other hand, during market turmoil, Aptamer Sciences is expected to outperform it slightly. Please check Aptamer Sciences' total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Aptamer Sciences' price patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Aptamer Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Aptamer Sciences sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | -58 M |
Aptamer |
Aptamer Sciences Relative Risk vs. Return Landscape
If you would invest 168,046 in Aptamer Sciences on August 29, 2024 and sell it today you would earn a total of 26,954 from holding Aptamer Sciences or generate 16.04% return on investment over 90 days. Aptamer Sciences is generating 0.6396% of daily returns and assumes 9.392% volatility on return distribution over the 90 days horizon. Simply put, 83% of stocks are less volatile than Aptamer, and 88% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Aptamer Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptamer Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aptamer Sciences, and traders can use it to determine the average amount a Aptamer Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0681
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 291650 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.39 actual daily | 83 83% of assets are less volatile |
Expected Return
| 0.64 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Aptamer Sciences is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptamer Sciences by adding it to a well-diversified portfolio.
Aptamer Sciences Fundamentals Growth
Aptamer Stock prices reflect investors' perceptions of the future prospects and financial health of Aptamer Sciences, and Aptamer Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aptamer Stock performance.
| Return On Equity | -19.57 | |||
| Return On Asset | -0.11 | |||
| Operating Margin | (14.32) % | |||
| Current Valuation | 169.03 B | |||
| Revenue | 269.28 M | |||
| EBITDA | (3.49 B) | |||
| Cash And Equivalents | 1.01 B | |||
| Total Debt | 68.63 M | |||
| Cash Flow From Operations | (3.47 B) | |||
| Total Asset | 33.26 B | |||
About Aptamer Sciences Performance
By analyzing Aptamer Sciences' fundamental ratios, stakeholders can gain valuable insights into Aptamer Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aptamer Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aptamer Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Aptamer Sciences, Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. Aptamer Sciences, Inc. was founded in 2011 and is headquartered in Seongnam, South Korea. Aptamer Sciences is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Aptamer Sciences performance evaluation
Checking the ongoing alerts about Aptamer Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aptamer Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aptamer Sciences is way too risky over 90 days horizon | |
| Aptamer Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 269.28 M. Net Loss for the year was (3.83 B) with profit before overhead, payroll, taxes, and interest of 157.44 M. | |
| Aptamer Sciences has accumulated about 1.01 B in cash with (3.47 B) of positive cash flow from operations. | |
| Roughly 33.0% of the company shares are owned by insiders or employees |
- Analyzing Aptamer Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aptamer Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Aptamer Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aptamer Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aptamer Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aptamer Sciences' stock. These opinions can provide insight into Aptamer Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aptamer Stock analysis
When running Aptamer Sciences' price analysis, check to measure Aptamer Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptamer Sciences is operating at the current time. Most of Aptamer Sciences' value examination focuses on studying past and present price action to predict the probability of Aptamer Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptamer Sciences' price. Additionally, you may evaluate how the addition of Aptamer Sciences to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |